Orphan drug designation schedule for VascoStem, a stem cell treatment agent for Buerger’s disease, changed by MFDS
The Biostar Stem Cell Research Institute, jointly operated by Nature Cell and R Bio, announced on August 21 that it has been notified by the Ministry of Food and Drug Safety (MFDS) that the date of decision-making regarding the orphan drug designation of VascoStem, a stem cell treatment agent for Buerger’s disease, has been postponed to September 14.
Read more
Most Commented